|
ZSCAN29 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.59889879114417E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.29610000088843E-09 |
| Normal-vs-Stage2 |
2.40459999999443E-05 |
| Normal-vs-Stage3 |
6.7324035235572E-11 |
| Normal-vs-Stage4 |
3.94669996683916E-09 |
| Stage1-vs-Stage2 |
9.994000E-01 |
| Stage1-vs-Stage3 |
2.134100E-02 |
| Stage1-vs-Stage4 |
3.841900E-02 |
| Stage2-vs-Stage3 |
1.126430E-01 |
| Stage2-vs-Stage4 |
9.104400E-02 |
| Stage3-vs-Stage4 |
7.636800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.07269970683888E-10 |
| Normal-vs-AfricanAmerican |
5.69200000000158E-05 |
| Normal-vs-Asian |
1.834420E-04 |
| Caucasian-vs-AfricanAmerican |
7.395400E-01 |
| Caucasian-vs-Asian |
2.142400E-01 |
| AfricanAmerican-vs-Asian |
2.590000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.06669999500042E-08 |
| Normal-vs-Female |
4.51979564886074E-11 |
| Male-vs-Female |
6.659000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.22880000513948E-09 |
| Normal-vs-Age(41-60Yrs) |
2.14499995543349E-09 |
| Normal-vs-Age(61-80Yrs) |
1.015499995205E-08 |
| Normal-vs-Age(81-100Yrs) |
2.617300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.543200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.099200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.287790E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.740800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.628800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.604800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.380400E-04 |
| Classical-VS-Follicular |
4.902000E-01 |
| Classical-VS-Other |
4.138200E-01 |
| Classical-VS-Normal |
2.96519997444733E-09 |
| Tall-VS-Follicular |
9.835800E-03 |
| Tall-VS-Other |
4.162800E-01 |
| Tall-VS-Normal |
1.86549997671648E-10 |
| Follicular-VS-Other |
6.184000E-01 |
| Follicular-VS-Normal |
8.11789999999313E-07 |
| Other-VS-Normal |
7.644300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.58389995458452E-09 |
| Normal-vs-N1 |
2.66599999998451E-06 |
| N0-vs-N1 |
8.396200E-01 |
|
|
